134922-49-9

Upstream product

• 3323-72-6 ethyl 4,6-di-O-acetyl-2,3-dideoxy-α-D-erythrohex-2-enopyranoside 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 134948-79-1 Ethyl 4-O-(tert-butyldimethylsilyl)-2,3-dideoxy-6-O-pivaloyl-α-D-erythro-hex-2-enopyranoside 
• 130335-92-1 Ethyl 4-O-(tert-butyldimethylsilyl)-6-cyclohexylidene-2,3,6-trideoxy-α-D-erythro-hex-2-enoaldopyranoside-(1,5) 
• 112571-70-7 Ethyl 4-O-(tert-butyldimethylsilyl)-2,3-dideoxy-α-D-erythro-hex-2-enodialdopyranoside-(1,5) 
• 134934-18-2 Ethyl 4-O-(tert-butyldimethylsilyl)-2,3-dideoxy-α-D-erythro-hex-2-enopyranoside 
• 130316-22-2 <5S-(5α,6β)>-5-<(tert-Butyldimethylsilyl)oxy>-6-(cyclohexylidenemethyl)-5,6-dihydro-2H-pyran-2-one 

Relevant academic research and scientific papers

Synthesis of renin inhibitors possessing hydroxyethylene isostere residue from 3,4,6-tri-O-acetyl-D-glucal via lactone precursor

Syntheses of precursors for renin inhibitors possessing hydroxyethylene isostere residue from 2,4,6-tri-O-acetyl-D-glucal via lactone precursor is described . This route makes it possible to synthesize analogues with various substituents at C-2 and C-5 of